John G Ullman & Associates Inc Jazz Pharmaceuticals PLC Transaction History
John G Ullman & Associates Inc
- $649 Million
- Q3 2024
A detailed history of John G Ullman & Associates Inc transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, John G Ullman & Associates Inc holds 45,094 shares of JAZZ stock, worth $5.71 Million. This represents 0.77% of its overall portfolio holdings.
Number of Shares
45,094
Previous 56,494
20.18%
Holding current value
$5.71 Million
Previous $6.03 Million
16.64%
% of portfolio
0.77%
Previous 0.96%
Shares
3 transactions
Others Institutions Holding JAZZ
# of Institutions
511Shares Held
57.7MCall Options Held
188KPut Options Held
133K-
Black Rock Inc. New York, NY6.15MShares$778 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.11MShares$774 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.49MShares$316 Million0.6% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.1MShares$266 Million0.56% of portfolio
-
State Street Corp Boston, MA1.95MShares$247 Million0.01% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $7.94B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...